• Daniel H Lee, Jamie Stang, Robert F Reardon, Marc L Martel, Brian E Driver, and Darren A Braude.
• Department of Emergency Medicine, Hennepin County Medical Center, Minneapolis, Minnesota. Electronic address: Leex7159@umn.edu.
• J Emerg Med. 2021 Nov 1; 61 (5): 550-557.

BackgroundThe administration of sedation and neuromuscular blockade to facilitate extraglottic device (EGD) placement is known as rapid sequence airway (RSA). In the emergency department (ED), EGDs are used largely as rescue devices. In select patients, there may be significant advantages to using EGDs over laryngoscopy as the primary airway device in the ED.ObjectiveOur study sought to describe the practice of RSA in the ED, including rates of successful oxygenation, ventilation, and complications from EGD use.MethodsWe identified patients in the ED between 2007 and 2017 who underwent RSA with the LMA® Fastrach™ (hereafter termed ILMA; Teleflex Medical Europe Ltd., Athlone, Ireland) placed as the first definitive airway management device. A trained abstractor performed chart and video review of the cases to determine patient characteristics, physician use of the ILMA, indication for ILMA placement, success of oxygenation and ventilation, success of intubation, and complications related to the device.ResultsDuring the study period, 94 patients underwent RSA with the ILMA. Of those, 93 (99%) were successfully oxygenated and ventilated, and when intubation was attempted, 89% were able to be intubated through the ILMA. The incidence of vomiting and aspiration was 1% and 3%, respectively. There were 30 different attending physicians who supervised RSA and the median number was 2 per physician in the 10-year study period.ConclusionThe practice of RSA with the ILMA in the ED is associated with a high rate of successful oxygenation, ventilation, and intubation with infrequent complications, even when performed by physicians with few experiences in the approach.Copyright © 2021 Elsevier Ltd. All rights reserved.

12 keywords...

hide…